Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-22

Clinical Trial Update: Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

View source ↗

Summary

Clinical trial update describing clinical and laboratory abnormalities in patients with defective DNA repair due to Xeroderma Pigmentosum, Cockayne syndrome, or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cockayne Syndrome, Skin Neoplasms | Status: COMPLETED